Cargando…

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans

Human influenza virus infections with avian subtype H7N9 viruses are a major public health concern and have encouraged the development of effective H7 prepandemic vaccines. In this study, baseline and postvaccination serum samples of individuals aged 18 years and older who received a recombinant H7...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stadlbauer, Daniel, Rajabhathor, Arvind, Amanat, Fatima, Kaplan, Daniel, Masud, Abusaleh, Treanor, John J., Izikson, Ruvim, Cox, Manon M., Nachbagauer, Raffael, Krammer, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729220/ https://www.ncbi.nlm.nih.gov/pubmed/29242836 http://dx.doi.org/10.1128/mSphere.00502-17

Ejemplares similares

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans
por: Nachbagauer, Raffael, et al.
Publicado: (2016)

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
por: Rajendran, Madhusudan, et al.
Publicado: (2017)

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model
por: Stadlbauer, Daniel, et al.
Publicado: (2018)

FluBlok, a recombinant hemagglutinin influenza vaccine
por: Cox, Manon M.J., et al.
Publicado: (2008)

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations
por: Rajendran, Madhusudan, et al.
Publicado: (2018)

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts
por: Nachbagauer, Raffael, et al.
Publicado: (2019)

Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice
por: Wang, Jiong, et al.
Publicado: (2018)

A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study
por: Nachbagauer, Raffael, et al.
Publicado: (2018)

Novel correlates of protection against pandemic H1N1 influenza A virus infection
por: Ng, Sophia, et al.
Publicado: (2019)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
por: Liu, Wen-Chun, et al.
Publicado: (2019)

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
por: Wohlbold, Teddy John, et al.
Publicado: (2015)

Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults
por: Maier, Hannah E, et al.
Publicado: (2020)

Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model
por: Liu, Wen-Chun, et al.
Publicado: (2021)

Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
por: Hernandez-Davies, Jenny E., et al.
Publicado: (2021)

Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate
por: Tran, Erin E. H., et al.
Publicado: (2016)

A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
por: Broecker, Felix, et al.
Publicado: (2019)

Hemagglutinin Stalk Antibody Responses Following Trivalent Inactivated Influenza Vaccine Immunization of Pregnant Women and Association With Protection From Influenza Virus Illness
por: Dhar, Nisha, et al.
Publicado: (2020)

An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus Antibodies
por: Behzadi, Mohammad Amin, et al.
Publicado: (2019)

Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 Hemagglutinin
por: Strohmeier, Shirin, et al.
Publicado: (2019)

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults
por: Meade, Philip, et al.
Publicado: (2020)

Erratum: Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
Publicado: (2021)

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine
por: Wang, Keyang, et al.
Publicado: (2006)

A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice
por: Bliss, Carly M., et al.
Publicado: (2022)

Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner
por: Mullarkey, Caitlin E., et al.
Publicado: (2016)

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
por: Jacobsen, Henning, et al.
Publicado: (2017)

SARS-CoV-2 Vaccines: Status Report
por: Amanat, Fatima, et al.
Publicado: (2020)

Vaccine effect of recombinant single-chain hemagglutinin protein as an antigen
por: Kawai, Atsushi, et al.
Publicado: (2020)

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
por: Izikson, Ruvim, et al.
Publicado: (2022)

Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice
por: Corder, Brigette N., et al.
Publicado: (2019)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
por: McMahon, Meagan, et al.
Publicado: (2019)

Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus
por: Klausberger, Miriam, et al.
Publicado: (2016)

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice
por: Liu, Yonghong, et al.
Publicado: (2021)

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2019)

Recombinant protein vaccines produced in insect cells
por: Cox, Manon M.J.
Publicado: (2012)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
por: Asthagiri Arunkumar, Guha, et al.
Publicado: (2019)

AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets
por: Stadlbauer, Daniel, et al.
Publicado: (2021)

Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
por: Zhang, Limin, et al.
Publicado: (2022)

Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice
por: Puente-Massaguer, Eduard, et al.
Publicado: (2023)

Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants
por: Hernandez-Davies, Jenny E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pljhtounf0gdm993rjr20nq6j9